Find your path to MARK
206 people in our graph share verified history with MARK — schools, employers, funds. One of them is your warm intro.
Robert TepperunlockedMARK: together at KALA BIO
MARK: together at KALA BIO
×4MARK: together at AstraZeneca - Astra Merck
×6MARK: together at Loyola University Maryland
Executive at KALA BIO
Intro paths
→
In turn, MARK can intro founders to KALA BIO's investors below.
KALA BIO's investors · 8
Atlas VentureCambridge · $500K – $1M checks · since 2015Longitude CapitalMenlo Park · $10M – $30M checksLux CapitalNew York · $100K – $100M checks · since 2021National Institutes of Health (NIH)RA CapitalBostonSR One Capital ManagementRedwood CityThird Rock VenturesBoston · $100K – $5M checks · since 2015Ysios CapitalBarcelona · $5.4M – $21.6M checks
Co-founders at KALA BIO
JH
Justin HanesDirector
KP
Kevin PojasekExecutive Officer
Experience
- Inhibikase Therapeutics, Inc.Chief Executive Officercurrent2025 — present
- Q32 Bio Inc.Board Chaircurrent2020 — present
- Nimbus TherapeuticsDirectorcurrent2015 — presentBoston
- KALA BIOBoard Chair2025 — 2026
- KALA BIOChairman and Chief Executive Officer2015 — 2025Greater Boston
- Akero TherapeuticsBoard Chair2019 — 2025
- MerusDirector2015 — 2025Netherlands
- Third Harmonic BioBoard Chair2020 — 2025San Francisco Bay Area
- Aerovate Therapeutics, Inc.Board Chair2021 — 2024Greater Boston
- Pulmatrix Inc.Director2015 — 2020Greater Boston
- Aimmune TherapeuticsDirector2015 — 2020San Francisco Bay Area
- Taris BiomedicalBoard Director2014 — 2018Boston
- Civitas TherapeuticsPresident and Chief Executive Officer2014Boston, Ma
- Blend TxPresident and Chief Executive Officer2012 — 2014Watertown, MA
- Sunovion Pharmaceuticals Inc.President and Chief Executive Officer2009 — 2012
- Sunovion Pharmaceuticals Inc.Chief Commercial Officer2007 — 2009Marlborough, MA
- NovartisSr. Vice President and Head Cardiovascular Business Unit2003 — 2007
- NovartisVice President & Business Unit Head Arthritis, Bone, GI, Women's Health, Urology, Infectious Disease1997 — 2003
- AstraZeneca - Astra MerckSales, Marketing, Health Economics and Outcomes Research1992 — 1997
- MerckSales1989 — 1991
Frequently asked questions
- Who is MARK IWICKI?
- Executive Officer, Director at Civitas Therapeutics
- Where does MARK IWICKI work?
- MARK IWICKI is Executive at KALA BIO.
- Where did MARK IWICKI go to school?
- MARK IWICKI studied at Loyola University Maryland (Master of Business Administration (MBA), Marketing & Finance); Ball State University (Bachelor of Science (B.S.), Business Administration and Management, General).
Same school
Also attended Loyola University Maryland52
Grayson BaxterFund Controller at JMI EquityMelissa GuttmanPrincipal, Talent at JMI EquityLiz WuestlingVice President, Business Analytics & Strategy at Northpond VenturesNona Minnifield CheeksVice Chair at Maryland TEDCOJessica Mullins CamburnChief Financial Officer at Glasswing VenturesRyan McQueeneyCFO at Acadian Ventures Management, Llc
+ 46 more
Also attended Ball State University23
Tony RimasVenture Partner at Autotech VenturesCy MegninVice President at Elevate VenturesTony PetruccianiPartner and CFO at Boomerang VenturesBen LakoffGeneral Partner at Bankless VenturesAudrey BeckmanPartner and Chief Innovation Officer at Boomerang VenturesJordan DetmersBusiness Development and Commercialization Manager at Ontario Centre of Innovation
+ 17 more
Shared employers
Also worked at Nimbus Therapeutics9
Erin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesVikas GoyalPartner at Longwood FundNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health InvestorsAlex Badamchi-ZadehVice President at SV Health Investors
+ 3 more
Also worked at Merus4
Also worked at Pulmatrix Inc.2
Also worked at Sunovion Pharmaceuticals Inc.10
Kaitlyn LagascaManager, Talent Acquisition at Anzu PartnersDario DollerCo-founder at Modulate BioFred GrossmanExecutive Officer at Coya TherapeuticsAntony LoebelExecutive Officer at Seaport TherapeuticsCurtis LockshinExecutive Officer at Xenetic BiosciencesTim HealeyChief Commercial Officer at Tenax Therapeutics
+ 4 more